tiprankstipranks
Advertisement
Advertisement
Merck & Company: Buy Rating Backed by Growth Prospects in Cardiopulmonary and Infectious Disease Franchises
PremiumRatingsMerck & Company: Buy Rating Backed by Growth Prospects in Cardiopulmonary and Infectious Disease Franchises
7d ago
Merck announces Health Canada approval for KEYTRUDA in cervical cancer
Premium
The Fly
Merck announces Health Canada approval for KEYTRUDA in cervical cancer
7d ago
Veeva announces Merck committed to Veeva Vault CRM
Premium
The Fly
Veeva announces Merck committed to Veeva Vault CRM
7d ago
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
PremiumThe FlyFDA willing to trade faster drug reviews for lower prices, Bloomberg reports
17d ago
Merck’s Bravecto Quantum parasiticide for dogs approved by FDA
Premium
The Fly
Merck’s Bravecto Quantum parasiticide for dogs approved by FDA
18d ago
Merck price target lowered to $98 from $99 at Morgan Stanley
Premium
The Fly
Merck price target lowered to $98 from $99 at Morgan Stanley
18d ago
Verona Pharma downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyVerona Pharma downgraded to Equal Weight from Overweight at Wells Fargo
19d ago
Verona Pharma downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Verona Pharma downgraded to Hold from Buy at TD Cowen
19d ago
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
Premium
The Fly
Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
19d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100